LIN28A Gene - RNA-Binding Protein Regulating Development and Cancer

Comprehensive genomic and functional analysis of LIN28A, a key regulator of stem cell pluripotency and oncogenesis

Gene Information Card

Symbol LIN28A
Full Name lin-28 homolog A
Gene Type protein-coding
Chromosomal Location 1p36.11
NCBI Gene ID 79727 ncbi.nlm.nih.gov/gene/79727
Ensembl ID ENSG00000131914
UniProt ID Q9H9Z2
OMIM ID 611043
HGNC ID 15986
Aliases LIN28, ZCCHC1, CSDD1

Description

LIN28A encodes a conserved RNA-binding protein that plays a critical role in development, stem cell pluripotency, and metabolism. It binds to the let-7 family of microRNAs and blocks their maturation, thereby promoting self-renewal and proliferation. LIN28A is frequently overexpressed in various cancers and is associated with poor prognosis. It also interacts with mRNAs involved in cell growth and differentiation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (multiple types) LIN28A overexpression suppresses let-7 microRNA biogenesis, leading to de-repression of oncogenes such as MYC and RAS. COSMIC, ClinVar
Primordial Dwarfism (rare) Germline missense mutations in LIN28A disrupt RNA-binding and let-7 regulation, impairing growth. OMIM #611043, ClinVar
Type 2 Diabetes (associated) LIN28A variants influence insulin sensitivity and glucose metabolism via let-7 targets. NCBI Gene, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Placenta 8.2 Medium
Brain (cerebellum) 4.1 Low
Liver 1.3 Low
Heart 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
H1 (embryonic stem cell) 15.0 High expression; consistent with stem cell role
HeLa (cervical carcinoma) 9.5 Overexpressed
MCF7 (breast cancer) 7.2 Overexpressed
K562 (leukemia) 3.1 Moderate
HEK293 (embryonic kidney) 2.0 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.200G>A (p.Arg67His) Missense <0.1% Reduced RNA-binding affinity; associated with primordial dwarfism
c.337C>T (p.Arg113Trp) Missense <0.1% Impaired let-7 repression; linked to growth disorders
Amplification Copy number gain 5-10% in cancers Increased LIN28A expression; promotes tumorigenesis
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg67His, p.Arg113Trp) reduce RNA-binding and let-7 inhibition, leading to developmental growth defects.

Gain of Function (GOF)

Gene amplification or overexpression in cancers enhances let-7 suppression, driving oncogene activation and proliferation.

Dominant Negative (DN)

Not reported for LIN28A.

Pathways

let-7 inhibition of oncogenes (MYC
RAS
HMGA2)
Pluripotency and self-renewal (OCT4
NANOG
SOX2)
Insulin/IGF signaling and glucose metabolism

Protein Summary

LIN28A is a 209-amino acid RNA-binding protein containing a cold-shock domain (CSD) and two CCHC zinc finger motifs. It binds to the terminal loop of let-7 precursor microRNAs and recruits the TUTase ZCCHC11 to add oligo(U) tails, blocking Dicer processing and promoting degradation. LIN28A also interacts with mRNAs encoding ribosomal proteins and metabolic enzymes. Its expression is high in embryonic stem cells and many cancers, where it maintains an undifferentiated, proliferative state.

Related Products

Product name Cat.No. Species Gene ID
LIN28A Knockout HEK293 Cell Line EDJ-KQ14079 Human 79727 Details Get a Quote
LIN28A Knockout HeLa Cell Line EDJ-KQ57212 Human 79727 Details Get a Quote
LIN28A Knockout A-549 Cell Line EDJ-KQ65727 Human 79727 Details Get a Quote
LIN28A Knockout HCT 116 Cell Line EDJ-KQ74144 Human 79727 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: